Liu Ling, Yang Fang, Li Min, Hou Huajuan, Yin Qin, Zhang Renliang
Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, PR China.
Interv Neurol. 2015 Jan;3(1):56-66. doi: 10.1159/000369481.
This study aimed to investigate the clinical and angiographic characteristics of ischemic stroke of undetermined etiology in young Chinese adults and to observe the effects of medication on their long-term outcomes.
A total of 179 consecutive young patients with ischemic stroke of undetermined etiology were retrospectively analyzed for clinical and angiographic characteristics, laboratory tests, the choice of drug treatment, and follow-up outcomes. Any predictive power for recurrent stroke and new lesions or aggravated stenosis was analyzed.
170 patients were clinically followed up for a median of 25 months (range, 4-92), and 65 patients with 114 lesions had angiographic follow-up for a median of 7 months. A total of 53 patients were enrolled in a routine medical management (RMM) group, and 117 were treated with corticosteroids plus RMM (aggressive medical management, AMM). Kaplan-Meier survival analysis revealed that differences in the 2-year cumulative stroke-free rate and in the 18-month cumulative worsening and/or new lesion-free rate between the RMM and AMM groups were significant (p < 0.05). Multivariate and Cox regression analyses revealed that the choice of drug therapy and erythrocyte sedimentation rate were associated with recurrent stroke, that AMM was independently associated with a decreased risk of worsening lesion, and that worsening lesion was the only independent predictor of recurrent stroke.
Compared with RMM, AMM is more efficacious in the prevention of secondary ischemic stroke and progressive arterial lesions among young adults with ischemic stroke of undetermined etiology.
本研究旨在调查中国年轻成年人病因不明的缺血性卒中的临床和血管造影特征,并观察药物治疗对其长期预后的影响。
对179例连续的病因不明的年轻缺血性卒中患者进行回顾性分析,包括临床和血管造影特征、实验室检查、药物治疗选择及随访结果。分析对复发性卒中、新病灶或狭窄加重的任何预测能力。
170例患者进行了中位时间为25个月(范围4 - 92个月)的临床随访,65例有114个病灶的患者进行了中位时间为7个月的血管造影随访。共53例患者纳入常规药物治疗(RMM)组,117例接受皮质类固醇加RMM治疗(积极药物治疗,AMM)。Kaplan-Meier生存分析显示,RMM组和AMM组在2年累积无卒中率以及18个月累积无病情恶化和/或新病灶率方面存在显著差异(p < 0.05)。多变量和Cox回归分析显示,药物治疗的选择和红细胞沉降率与复发性卒中相关,AMM与病变恶化风险降低独立相关,且病变恶化是复发性卒中的唯一独立预测因素。
与RMM相比,AMM在预防病因不明的年轻缺血性卒中患者的继发性缺血性卒中和进行性动脉病变方面更有效。